This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Madhunika Sharma: Innovator in Artemisinin Derivatives
Introduction
Madhunika Sharma is a prominent inventor based in Jammu, India. She has made significant contributions to the field of medicinal chemistry, particularly in the development of artemisinin derivatives. Her innovative work focuses on synthesizing novel compounds that have potential applications in cancer treatment.
Latest Patents
Madhunika Sharma holds a patent for a series of artemisinin derivatives and the process for their preparation. This invention relates to the synthesis of certain novel Baylis-Hillman adducts of artemisinin-derived aldehyde 2-[10'β-deoxoartemisininyl]-ethanal. The capabilities of introducing three functional groups into a molecule in one step using the Baylis-Hillman reaction encouraged her to synthesize highly functionalized derivatives of artemisinin. These derivatives have shown activity against various cancer cell lines, highlighting their potential therapeutic benefits.
Career Highlights
Madhunika Sharma is affiliated with the Council of Scientific and Industrial Research, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to addressing critical health challenges.
Collaborations
Madhunika has collaborated with notable colleagues, including Nabin Chandra Barua and Partha Pratim Saikia, to advance her research initiatives.
Conclusion
Madhunika Sharma's contributions to the field of medicinal chemistry, particularly through her patent on artemisinin derivatives, underscore her role as an influential inventor. Her work not only showcases her innovative spirit but also holds promise for future advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
